Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Optimal Dose of Corticosteroids in COPD Exacerbations: A Pilot Study

NCT01742338 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT01742338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01742338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Optimal Dose of Corticosteroids in COPD Exacerbations: A Pilot Study
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 4
Overall status
Terminated
Start date
May 3, 2012
Completion date
March 15, 2020
Enrollment
89 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd